I am accepting PhD students who have strong computation or programming skills to work on Big Data to evaluate medication use in neonates and children.
Current Research Opportunities
- Utilising data linkage to estimate antimicrobial resistance burden in paediatric populations
- Antibiotic use and lower respiratory tract infections burden in children during Coronavirus (COVID-19)
Public outreach & key achievements
In 2016, I established and led the first global paediatric surveillance program (Global Antimicrobial Resistance, Prescribing, and Efficacy Among Neonates and Children; GARPEC) to assess antibiotic use in hospitalized neonates and children. I have a number of papers published from my global projects (Lancet Infectious Diseases, Lancet Global Health, BMJ Global Health, WHO Bulletin).
Name: Colleen O’Sullivan
PhD title: Clinical application of applying machine learning algorithms to determine empirical antibiotic treatment in neonates and children with bloodstream infections
Years of Study: 2020
Country: Republic of Ireland
Name: Lydia Ewurabena Gamey
PhD title: The burden of vaccine preventable invasive pneumococcal diseases in paediatric population in the UK
Years of Study: 2021
Alumni: Where are they now